|
GTPBP10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62536650805123E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.22124532708767E-15 |
| Normal-vs-Stage2 |
1.370220E-04 |
| Normal-vs-Stage3 |
3.00830027555321E-10 |
| Normal-vs-Stage4 |
1.76789693995261E-11 |
| Stage1-vs-Stage2 |
1.644980E-01 |
| Stage1-vs-Stage3 |
7.487000E-01 |
| Stage1-vs-Stage4 |
1.732210E-01 |
| Stage2-vs-Stage3 |
1.331970E-01 |
| Stage2-vs-Stage4 |
3.272200E-02 |
| Stage3-vs-Stage4 |
3.322800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.10782519111308E-15 |
| Normal-vs-AfricanAmerican |
1.816950E-04 |
| Normal-vs-Asian |
1.62080016075095E-10 |
| Caucasian-vs-AfricanAmerican |
2.782600E-01 |
| Caucasian-vs-Asian |
3.062800E-01 |
| AfricanAmerican-vs-Asian |
7.863600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.73530087468998E-11 |
| Normal-vs-Female |
1.8025581027814E-12 |
| Male-vs-Female |
1.913420E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.06934469559883E-12 |
| Normal-vs-Age(41-60Yrs) |
3.67927910360777E-12 |
| Normal-vs-Age(61-80Yrs) |
2.22699969576468E-10 |
| Normal-vs-Age(81-100Yrs) |
3.558300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.813200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.881400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.285200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.911600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.082400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.985800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.075700E-02 |
| Classical-VS-Follicular |
2.622400E-01 |
| Classical-VS-Other |
1.332230E-01 |
| Classical-VS-Normal |
7.88070053658885E-10 |
| Tall-VS-Follicular |
2.185600E-02 |
| Tall-VS-Other |
3.787000E-01 |
| Tall-VS-Normal |
1.66749947183575E-10 |
| Follicular-VS-Other |
1.345410E-01 |
| Follicular-VS-Normal |
1.4802000000147E-06 |
| Other-VS-Normal |
1.805860E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.95465907085691E-12 |
| Normal-vs-N1 |
5.34280397701536E-11 |
| N0-vs-N1 |
7.591800E-02 |
|
|
